An Illinois woman delivered her first child in 1999 by cesarean delivery and minutes thereafter experienced uterine atony with severe blood loss.
The defense claimed that the patient's uterus did not contract in spite of uterine massage, uterine compression, and administration of medications, including carboprost tromethamine, oxytocin, and methylergonovine. They argued that there was not sufficient time to perform uterine artery ligation, given the profuse life-threatening bleeding and the patient's unstable condition.
A defense verdict was returned in 2005, but a new trial was granted and resulted in a $5 million verdict. The matter ultimately was settled posttrial for $2 million.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More